Since May, highly contagious "FLiRT" coronavirus variants – a term for new mutations of Omicron – have been driving a rise in infections and emergency room trips. Virus levels at local wastewater ...

We conducted a phase 2–3 double-blind trial to assess the efficacy and safety of nirmatrelvir–ritonavir in asymptomatic, rapid antigen test–negative adults who had been exposed to a household contact ...

Coronavirus transmission has been slowly, but steadily, on the rise in recent weeks — and though local public health officials say the most recently available data doesn’t yet indicate a surge akin to ...

Nirmatrelvir in combination with ritonavir is an antiviral treatment for mild-to-moderate coronavirus disease 2019 (Covid-19). The efficacy of this treatment in patients who are at standard risk for ...

Pew Research Center conducted this study to understand Americans’ views of the coronavirus and COVID-19 vaccines. For this analysis, we surveyed 10,133 U.S. adults from Feb. 7 to 11, 2024. Everyone ...

It’s late August, there’s a hurricane coming up the East Coast, schools are starting to open, and no one has any idea who can get an updated Covid-19 shot. The Covid-19 pandemic is over, but the virus ...

The vaccine is expected to be commercially ready for the 2025-2026 COVID-19 season. The Food and Drug Administration (FDA) has approved Nuvaxovid ™ (COVID-19 Vaccine, Adjuvanted) for active ...

The ongoing coronavirus disease 2019 (COVID-19) pandemic, caused by the rapid outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has severely affected the global economy and ...

In a recent Morbidity and Mortality Weekly Report (MMWR), the United States Centers for Disease Control and Prevention (CDC) reported how coronavirus disease 2019 (COVID-19) mortality rates varied ...

Children born to mothers infected with covid-19 during pregnancy faced a higher risk of autism, along with other neurological differences such as delays in speech and motor development, according to a ...